In the evolving landscape of post-pandemic medicine, surgeons are discovering that the biological footprint of COVID-19 may extend far beyond the initial infection, potentially altering the safety profile of elective and reconstructive procedures. A significant new study published in the November issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—has identified a concerning trend: patients with a history of COVID-19 infection face a markedly higher risk of developing venous thromboembolism (VTE) following panniculectomy.
As weight-loss surgery and subsequent body contouring procedures become increasingly common, this discovery represents a critical pivot point in how plastic surgeons assess surgical candidates. The findings suggest that the hypercoagulable state—a lingering tendency for blood to clot—induced by the SARS-CoV-2 virus may necessitate a reevaluation of preoperative protocols and postoperative care.
Main Facts: The Intersection of Panniculectomy and Viral History
Panniculectomy is a functional, reconstructive procedure designed to excise the "pannus"—the apron of excess skin and subcutaneous fat that often remains after massive weight loss. While the surgery significantly improves a patient’s quality of life by addressing chronic skin infections, rashes, and mobility limitations, it is not without risk.
Venous thromboembolism, which encompasses deep vein thrombosis (DVT) and the potentially fatal pulmonary embolism (PE), remains one of the most feared complications in major abdominal surgery. The study’s lead author, Mary Newland, BS, a medical student at Penn State College of Medicine, underscores that while standard risk-mitigation strategies (such as the use of the Caprini risk assessment score and prophylactic anticoagulants) are universal, the "COVID factor" has emerged as a new, silent variable that may render these standard measures insufficient for a subset of the population.
The core finding is stark: in the study’s cohort, patients who had previously contracted COVID-19 were nearly twice as likely to suffer from a VTE post-surgery compared to their non-infected counterparts.
A Chronological Look at the Data
To understand the scope of this risk, researchers conducted a comprehensive retrospective analysis of national hospital data covering a six-year period from 2017 to 2023. This timeline allowed for a natural comparison between pre-pandemic surgical outcomes and those occurring in the wake of the global health crisis.
The Pre-Pandemic Baseline (2017–March 2020)
During the initial phase of the study, researchers tracked patients undergoing panniculectomy prior to the arrival of COVID-19. During this window, the incidence of VTE was calculated at 3.2%. This figure served as the benchmark for surgical safety in an era before the systemic physiological impacts of SARS-CoV-2 were recognized in clinical practice.
The Pandemic Era (March 2020–2023)
When researchers transitioned to the post-pandemic cohort, they initially noted a seemingly stable rate of VTE at 3.0%. However, this aggregate number masked a deeper, more volatile reality. By segregating the 4,099 patients who underwent surgery after March 2020 based on their infection status, the researchers uncovered a clear discrepancy.
When comparing the 790 patients with a documented history of COVID-19 against the 3,309 patients who had never been infected, the data revealed a significant divergence. The VTE rate for the COVID-positive group spiked to 4.9%, while the rate for the non-infected group dropped to 2.5%. This statistical significance suggests that the virus leaves a lasting mark on the vascular system that standard risk scores are not currently capturing.
Supporting Data: Why the Body Clots
The physiological mechanism behind this increased risk is largely attributed to the systemic inflammation associated with COVID-19. SARS-CoV-2 is known to cause endothelial dysfunction—damage to the lining of the blood vessels—and a state of persistent hypercoagulability.
In the context of major surgery, which naturally induces a trauma response and inflammatory state, the body is already primed for clotting. When an "activated" or previously damaged vascular system meets the surgical stress of a panniculectomy, the likelihood of thrombus formation increases exponentially.
The study is particularly robust because it controlled for other traditional risk factors. When comparing the two groups, the researchers found that comorbidities such as pre-existing heart disease, lung disease, and vascular conditions were evenly distributed. This strongly indicates that the history of COVID-19, rather than other underlying health issues, was the independent driver of the increased VTE incidence.
Official Perspectives and Clinical Implications
The implications of these findings are profound for the field of plastic and reconstructive surgery. Lead author Mary Newland notes, "Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy. This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
The Need for Revised Protocols
Currently, plastic surgeons rely on the Caprini score to determine the intensity of blood-thinning (anticoagulant) therapy required. The study suggests that this tool may need to be modified or supplemented to include a "COVID history" marker.
Some clinical experts are beginning to discuss whether patients with recent or even distant COVID-19 infections should undergo additional hematological screening, such as D-dimer testing, or if they should be placed on a more aggressive prophylactic medication regimen for a longer duration post-surgery. The challenge, of course, is balancing the need for VTE prevention with the risks of over-anticoagulation, which can lead to hematomas and other surgical site complications.
A New Patient Population
The study concludes that these findings define the "emergence of a new patient population." As the global population continues to age and recover from various waves of COVID-19, the number of surgical candidates with a history of infection will only increase. Surgeons must now treat a "history of COVID" as a vital piece of the patient’s clinical history, much like a history of smoking or hypertension.
Toward a Safer Future in Body Contouring
The publication of this study in Plastic and Reconstructive Surgery serves as a clarifier for practitioners worldwide. While the study calls for further research to confirm these associations and refine clinical guidelines, the immediate takeaway is clear: caution is warranted.
As plastic surgery continues to advance, the focus is shifting from simply achieving aesthetic or functional goals to perfecting the safety profile of complex procedures. The discovery that a prior viral infection can influence surgical outcomes years later highlights the interconnectedness of systemic health and local surgical interventions.
For patients considering panniculectomy, the message is not to avoid the surgery, but to ensure that their surgical team is fully aware of their COVID-19 history. For surgeons, the mandate is to continue adapting to a changing biological reality, ensuring that the life-changing benefits of body contouring are achieved with the highest possible standards of safety.
References and Further Reading
The full report, titled "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19" (doi: 10.1097/PRS.0000000000012202), is available in the November issue of Plastic and Reconstructive Surgery. Readers are encouraged to consult their surgical teams regarding individual risk profiles and the latest evidence-based protocols for VTE prevention.
About Wolters Kluwer: Wolters Kluwer is a global leader in professional information and software solutions, supporting healthcare providers and researchers with the data necessary to improve patient outcomes. Headquartered in the Netherlands, the company remains at the forefront of providing the medical community with the latest peer-reviewed evidence to guide clinical practice.
About the Author
